
Reunion Neuroscience Investor Relations Material
Latest events

Q3 2023
Reunion Neuroscience
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Reunion Neuroscience Inc
Access all reports
Reunion Neuroscience Inc. is a biotechnology company focused on developing innovative treatments for mental health conditions, with a particular emphasis on psychedelic-inspired therapies. The company’s lead programs are aimed at addressing major depressive disorder and other mental health challenges using novel compounds derived from psychedelics. Reunion Neuroscience seeks to advance clinical research and leverage its proprietary technologies to offer new treatment options for patients where traditional therapies may have limited effectiveness. The company is headquartered in Toronto, Canada, and its shares are listed on the Nasdaq.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
REUN
Country
🇺🇸 United States